4
Changes in Ownership
Definium Therapeutics, Inc. Filed Acc 0000950170-23-044853
Chief Financial Officer sold 20,000 shares at $3.80 ($76,000)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Greenway Schond L. Chief Financial Officer | 2023-08-25 | Sale | −20,000 | $3.80 | $76,000 | 228,031 | D |
| Open-market sales · 20,000 sh · avg $3.80 · $76,000 | |||||||
Loading xslF345X05/ownership.xml…